This was a prospective, randomised, double-blind, double-dummy, parallel-group, multicentre study conducted in 36 primary-care centres in Sweden in accordance with the 1996 Declaration of Helsinki.
Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates, clinicians may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback